Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Oct 29;33(5):819-821.
doi: 10.1093/icvts/ivab171.

Surgical management of an aortic root dilatation in a patient suffering from Hunter syndrome

Affiliations
Case Reports

Surgical management of an aortic root dilatation in a patient suffering from Hunter syndrome

Bastien Poitier et al. Interact Cardiovasc Thorac Surg. .

Abstract

Hunter syndrome is a rare disease leading to glycosaminoglycan accumulation in tissues. Multiple organs are involved, but prognosis is mainly conditioned by cardiac and respiratory failures. Cardiac valvular impairment is quite common but aortic root dilatation is rarely described. This article covers a case of surgical root replacement due to aortic valve insufficiency and aortic root dilatation documented with magnetic resonance and computed tomography angiographies. Anatomic pathology reported both aortic valve and aorta with mucoid overload and elastic fibre depletion. These patients do have a risk of aortic root dilatation, which justifies periodic monitoring. Diagnosis must be made using indexed measures.

Keywords: Aortic root dilatation; Aortic root replacement; Hunter syndrome.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Preoperative imaging: (A) aortic valve regurgitation evaluated on echocardiography and (B) sinuses of Valsalva dilatation on computed tomography angiography.
Figure 2:
Figure 2:
Pathology panel: (A) Macroscopic view of both aortic valve and aorta; (B) loss and fragmentation of elastic fibres in the aortic media (elastic stain; scale bar: 150 µm); (C) intracellular overload in the aortic media cells (Hematoxylin-eosin stain; scale bar: 50 µm); and (D) intracellular overload in the fibrotic aortic valve (Hematoxylin-eosin stain; scale bar: 150 µm).

References

    1. Demydchuk M, Hill CH, Zhou A, Bunkóczi G, Stein PE, Marchesan D. et al. Insights into Hunter syndrome from the structure of iduronate-2-sulfatase. Nat Commun 2017;8:15786. - PMC - PubMed
    1. Guffon N, Heron B, Chabrol B, Feillet F, Montauban V, Valayannopoulos V.. Diagnosis, quality of life, and treatment of patients with Hunter syndrome in the French healthcare system: a retrospective observational study. Orphanet J Rare Dis 2015;10:43. - PMC - PubMed
    1. D’Avanzo F, Rigon L, Zanetti A, Tomanin R.. Mucopolysaccharidosis type II: one hundred years of research, diagnosis, and treatment. Int J Mol Sci 2020;21. - PMC - PubMed
    1. Bolourchi M, Renella P, Wang RY.. Aortic root dilatation in mucopolysaccharidosis I-VII. Int J Mol Sci 2016;17. - PMC - PubMed
    1. Matura LA, Ho VB, Rosing DR, Bondy CA.. Aortic dilatation and dissection in Turner syndrome. Circulation 2007;116:1663–70. - PubMed

Publication types

MeSH terms